ResMed Inc. stock extends eight-day slide as market value drops

Published on 09/11/2026 at 18:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ResMed Inc. stock has fallen 8.6 percent over eight consecutive down sessions through September 11, 2026, erasing around USD 3.0 billion in market value. The shares closed at USD 219.58 on September 10, 2026, modestly softer than the broader market.

Unbranded CPAP-Gerät mit Atemmaske und Schlauch auf einem Nachttisch im Schlafzimmer — ResMed Inc. (ISIN US7611521078): generisches CPAP-Atemgerät mit Maske und Schlauch steht auf einem Nachttisch, Illustration mit AI erstellt.

ResMed Inc. stock (ISIN US7611521078) has declined 8.6 percent over eight straight trading sessions through September 11, 2026, cutting the company’s market value to about USD 32.0 billion and putting recent price weakness in clear focus for investors, according to analysis from Trefis on September 11, 2026.

Eight-day losing streak pressure on ResMed Inc. stock

As of September 11, 2026, ResMed Inc. stock has underperformed the broader equity market over multiple short- and medium-term horizons, with the 8.6 percent slide over the eight-day streak comparing with a 1.6 percent decline in the S&P 500 over the same period, according to Trefis.

Over the last one month (21 trading days) through September 11, 2026, ResMed has slipped 2.1 percent compared with a 1.8 percent decline in the S&P 500, while over the last three months (63 trading days) the stock still shows a gain of 13.8 percent versus 4.5 percent for the index, the same analysis from Trefis indicates.

Recent price levels and trading range

Per NYSE quote data referenced by Ad-hoc-news on September 11, 2026, ResMed Inc. stock (NYSE: RMD) closed at USD 219.58 on September 10, 2026, down 0.2 percent from the prior close, after trading between an intraday low of USD 218.15 and a high of USD 221.40.

The same quotation overview cited by Ad-hoc-news notes that roughly 814,600 ResMed shares changed hands on September 10, 2026, notably below a recent average volume of about 1.5 million shares, suggesting more subdued trading activity during the latest session.

According to the same report from Ad-hoc-news, the closing price of USD 219.58 on September 10, 2026 left ResMed shares in the upper half of their 52-week trading band, though below a recent quote of USD 219.95 referenced in an insider-trading context.

Market capitalization and performance context

The eight-day losing streak since late August has erased about USD 3.0 billion in ResMed’s market value, leaving the company with a market capitalization of approximately USD 32.0 billion as of September 11, 2026, according to Trefis.

The same analysis shows that on a year-to-date basis in 2026, ResMed Inc. stock is down 8.1 percent, compared with a positive 10.9 percent return for the S&P 500 over the same period, underscoring the relative underperformance of the healthcare equipment maker’s shares so far this year, based on data summarized by Trefis.

Historically, the same return table reproduced by Trefis highlights that ResMed delivered a 6.3 percent return in 2025, versus 16.4 percent for the S&P 500, illustrating that the stock has lagged the benchmark over the past full year as well.

Fundamentals and upcoming earnings date

Looking ahead, investors in ResMed Inc. stock are watching the next quarterly earnings release, with October 29, 2026 listed as the estimated date for the company’s upcoming report in an earnings calendar overview referenced by Ad-hoc-news, based on Yahoo Finance data.

The listing of October 29, 2026 as the estimated next earnings date positions a clear near-term milestone for the market, where investors will look for updated revenue trends, margins and guidance from ResMed’s management, as highlighted by Ad-hoc-news.

Recent commentary in the same article from Ad-hoc-news also notes that earlier CEO share sales had drawn attention in prior sessions, suggesting insider activity as one of the factors discussed in the market during recent trading, although no new insider transaction has been highlighted as of September 11, 2026.

ResMed Inc. stock price as of latest close

ResMed Inc. stock last closed at USD 219.58 on the NYSE on September 10, 2026, representing a 0.2 percent decline versus the prior session and reflecting comparatively light trading volume of around 814,600 shares, based on NYSE data cited by Ad-hoc-news.